TRIAL HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,463 JPY | +1.78% |
|
+4.32% | -.--% |
| May. 14 | Trial Holdings Inc. Provides Dividend Guidance for the Fiscal Year Ending June , 30, 2024 | CI |
| May. 14 | Trial Holdings Inc. Provides Earnings Guidance for the Year Ending June 30, 2024 | CI |
Valuation
| Fiscal Period: June | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 291,914 | - | - |
| Enterprise Value (EV) 1 | 261,607 | 262,931 | 269,043 |
| P/E ratio | 25 x | 22.3 x | 19 x |
| Yield | 0.52% | 0.71% | 0.79% |
| Capitalization / Revenue | 0.41 x | 0.37 x | 0.33 x |
| EV / Revenue | 0.36 x | 0.33 x | 0.31 x |
| EV / EBITDA | 8.37 x | 7.15 x | 6.34 x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | 2.64 x | 2.4 x | 2.17 x |
| Nbr of stocks (in thousands) | 118,520 | - | - |
| Reference price 2 | 2,463 | 2,463 | 2,463 |
| Announcement Date | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 718,658 | 795,644 | 880,462 |
| EBITDA 1 | - | 31,238 | 36,778 | 42,463 |
| EBIT 1 | - | 18,997 | 22,610 | 26,427 |
| Operating Margin | - | 2.64% | 2.84% | 3% |
| Earnings before Tax (EBT) 1 | - | 18,752 | 22,435 | 26,807 |
| Net income 1 | 8,084 | 11,009 | 13,493 | 15,823 |
| Net margin | - | 1.53% | 1.7% | 1.8% |
| EPS 2 | 82.90 | 98.42 | 110.6 | 129.8 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share 2 | - | 12.68 | 17.50 | 19.50 |
| Announcement Date | 2/14/24 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2024 S1 |
|---|---|
| Net sales 1 | 363,304 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 6,943 |
| Net margin | 1.91% |
| EPS | - |
| Dividend per Share 2 | - |
| Announcement Date | 2/14/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 30,307 | 28,982 | 22,870 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 15.4% | 12.9% | 13.5% |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 934.0 | 1,028 | 1,135 |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 2/14/24 | - | - | - |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,463
JPY
Average target price
3,300
JPY
Spread / Average Target
+33.98%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 1.86B | |
| +9.56% | 72.25B | |
| -10.87% | 65.31B | |
| +0.71% | 30.11B | |
| +35.09% | 26.26B | |
| +20.01% | 15.33B | |
| +32.12% | 11.69B | |
| +6.48% | 8.26B | |
| -2.78% | 6.95B | |
| +8.62% | 5.05B |
- Stock Market
- Equities
- 141A Stock
- Financials Trial Holdings Inc.
